Geoff Meacham

Geoff Meacham, PhD is a senior equity analyst and managing director at Bank of America covering the biotechnology and pharmaceutical industries. Prior to BofA, Geoff was an equity analyst covering the biotech/pharma industries at Barclays for the past 5 years and biotechnology at JP Morgan for 10 years prior to that. Geoff has spent a total of 20 years on the sell side and has been ranked #2 in the Institutional Investor poll for more than half of that time. Geoff has a PhD in molecular cell biology from UAB and a BS in biology/microbiology from Univ of Georgia. In addition to working in the financial services industry, Geoff’s has also worked within the biopharma industry at Solvay Pharmaceuticals and is an active member in the Cystic Fibrosis Center at Emory University.